Moura, Filipe A <br/><br/>
Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.  [electronic resource] 

 -  Atherosclerosis  Nov 2015 
 - 124-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1484 
<br/><br/><label>Standard No.: </label>10.1016/j.atherosclerosis.2015.09.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--analysis<br/>Brachial Artery--pathology<br/>C-Reactive Protein--analysis<br/>Coronary Angiography<br/>Diabetes Mellitus<br/>Diet<br/>Endothelium, Vascular--physiopathology<br/>Female<br/>Follow-Up Studies<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Inflammation<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Nitric Oxide--chemistry<br/>Patient Admission<br/>Percutaneous Coronary Intervention<br/>Prospective Studies<br/>ROC Curve<br/>Risk Factors<br/>Sensitivity and Specificity<br/>Treatment Outcome